MedTrace Logo

Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD

NCT03096236 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-09-18

No results posted yet for this study

Summary

Subepithelial gastric tumors are rare and usually detected incidentally. Most subepithelial tumors (SET) are benign but up to 13% of all lesions can be malignant. Histology after needle biopsy often brings no clear diagnosis in SET, so further strategy often remains unclear. Surveillance endoscopy can be associated with the risk of progression. Endoscopic resection usually is difficult, associated with high risk of complications and sometimes is not feasible. Surgical resection is also associated with a risk of complications and often refused by the patients. With the developement of the gFTRD-System gastric SET can now be resected endoscopically. The advantage of this technique is the complete resection and a full-thickness resections specimen for are definite histology.

Conditions

  • Feasibility, Complications

Interventions

DEVICE

EFTR

EFTR with the FTRD developed for gastric resection (gFTRD).

Sponsors & Collaborators

  • Kliniken Ludwigsburg-Bietigheim gGmbH

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-03-01
Completion
2019-09-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096236 on ClinicalTrials.gov